The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mahmoud, 2002, Strategies for transgenic manipulation of monoterpene biosynthesis in plants, Trends Plant Sci, 7, 366, 10.1016/S1360-1385(02)02303-8
Guimarães, 2013, Monoterpenes with analgesic activity: a systematic review, Phytother Res, 27, 1, 10.1002/ptr.4686
de Cássia da Silveira e Sá, 2013, A review on anti-inflammatory activity of monoterpenes, Molecules, 18, 1227, 10.3390/molecules18011227
Bhalla, 2013, Anticancer activity of essential oils: A review, J Sci Food Agric, 93, 3643, 10.1002/jsfa.6267
Barreto, 2014, A systematic review of the wound-healing effects of monoterpenes and iridoid derivatives, Molecules, 19, 846, 10.3390/molecules19010846
Hasan, 2015, Geraniol attenuates 2-acetylamino-fluorene induced oxidative stress, inflammation and apoptosis in the liver of wistar rats, Toxicol Mech Methods, 25, 559
Medicherla, 2015, Oral administration of geraniol ameliorates acute experimental murine colitis by inhibiting pro-inflammatory cytokines and NF-κB signaling, Food Funct, 6, 2984, 10.1039/C5FO00405E
Soubh, 2015, Geraniol ameliorates TNBS-induced colitis: Involvement of Wnt/β-catenin, p38MAPK, NF-κB, and PPARγ signaling pathways, Life Sci, 136, 142, 10.1016/j.lfs.2015.07.004
Kozioł, 2014, An overview of the pharmacological properties and potential applications of natural monoterpenes, Mini Rev Med Chem, 14, 1156, 10.2174/1389557514666141127145820
Gould, 1997, Cancer chemoprevention and therapy by monoterpenes, Environ Health Perspect, 105, 977, 10.1289/ehp.97105s4977
Crowell, 1999, Prevention and therapy of cancer by dietary monoterpenes, J Nutr, 129, 775S, 10.1093/jn/129.3.775S
Chen, 2015, Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy, Am J Cancer Res, 5, 1580
Samaila, 2004, Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro, Anticancer Res, 24, 3089
Bardon, 2002, Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression, Cancer Lett, 181, 187, 10.1016/S0304-3835(02)00047-2
Sobral, 2014, Antitumor activity of monoterpenes found in essential oils, Sci World J, 2014, 953451, 10.1155/2014/953451
Lapczynski, 2008, Fragrance material review on geraniol, Food Chem Toxicol, 46, S160, 10.1016/j.fct.2008.06.048
Solórzano-Santos, 2012, Essential oils from aromatic herbs as antimicrobial agents, Curr Opin Biotechnol, 23, 136, 10.1016/j.copbio.2011.08.005
Tiwari, 2009, Plant derived antioxidants - Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress, Toxicol In Vitro, 23, 295, 10.1016/j.tiv.2008.12.014
de Carvalho, 2014, Geraniol - a flavoring agent with multifunctional effects in protecting the gastric and duodenal mucosa, Naunyn Schmiedebergs Arch Pharmacol, 387, 355, 10.1007/s00210-013-0947-z
Rekha, 2013, Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson's disease, J Mol Neurosci, 51, 851, 10.1007/s12031-013-0074-9
Burke, 1997, Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol, Lipids, 32, 151, 10.1007/s11745-997-0019-y
Carnesecchi, 2001, Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells, J Pharmacol Exp Ther, 298, 197
Duncan, 2004, Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity, Biochem Pharmacol, 68, 1739, 10.1016/j.bcp.2004.06.022
Ong, 2006, Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase, Carcinogenesis, 27, 1194, 10.1093/carcin/bgi291
Kim, 2011, Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways, Biochem Biophys Res Commun, 407, 129, 10.1016/j.bbrc.2011.02.124
Galle, 2014, Suppression by geraniol of the growth of A549 human lung adenocarcinoma cells and inhibition of the mevalonate pathway in culture and in vivo: Potential use in cancer chemotherapy, Nutr Cancer, 66, 888, 10.1080/01635581.2014.916320
Carnesecchi, 2002, Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment, J Pharmacol Exp Ther, 301, 625, 10.1124/jpet.301.2.625
Carnesecchi, 2004, Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts, Cancer Lett, 215, 53, 10.1016/j.canlet.2004.06.019
Polo, 2006, Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2, Biochem Cell Biol, 84, 102, 10.1139/o05-160
Kim, 2012, Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells, Int J Oncol, 40, 1683
Crespo, 2013, Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways, Biochem Cell Biol, 91, 131, 10.1139/bcb-2012-0076
Zimmermann, 2007, Multi-target therapeutics: When the whole is greater than the sum of the parts, Drug Discov Today, 12, 34, 10.1016/j.drudis.2006.11.008
Efferth, 2011, Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy, Curr Drug Targets, 12, 122, 10.2174/138945011793591626
Rather, 2013, Multicomponent phyto-therapeutic approach gaining momentum: Is the ‘one drug to fit all’ model breaking down?, Phytomedicine, 21, 1, 10.1016/j.phymed.2013.07.015
Tao, 2015, Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs, Pharmacol Res, 102, 123, 10.1016/j.phrs.2015.09.019
Huang, 2013, How to escape the cancer attractor: Rationale and limitations of multi-target drugs, Semin Cancer Biol, 23, 270, 10.1016/j.semcancer.2013.06.003
Floor, 2012, Hallmarks of cancer: Of all cancer cells, all the time?, Trends Mol Med, 18, 509, 10.1016/j.molmed.2012.06.005
Ellenbroek, 2014, Imaging hallmarks of cancer in living mice, Nat Rev Cancer, 14, 406, 10.1038/nrc3742
Horne, 2015, Evolutionary mechanism unifies the hallmarks of cancer, Int J Cancer, 136, 2012, 10.1002/ijc.29031
Sonnenschein, 2013, The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique, J Biosci, 38, 651, 10.1007/s12038-013-9335-6
Carnesecchi, 2002, Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells, J Pharmacol Exp Ther, 303, 711, 10.1124/jpet.102.039263
Hoshi, 2012, Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab, Mod Rheumatol, 22, 122, 10.3109/s10165-011-0488-6
Chaudhary, 2013, Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis, J Appl Toxicol, 33, 828, 10.1002/jat.2739
Vinothkumar, 2012, Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch carcinogenesis, Mol Cell Biochem, 369, 17, 10.1007/s11010-012-1364-1
Cardozo, 2011, Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: Distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA, J Nutr Biochem, 22, 130, 10.1016/j.jnutbio.2009.12.007
Wiseman, 2007, Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21Cip1 and p27Kip1 in human pancreatic adenocarcinoma cells, J Pharmacol Exp Ther, 320, 1163, 10.1124/jpet.106.111666
Vieira, 2011, Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis, Braz J Med Biol Res, 44, 538, 10.1590/S0100-879X2011000600007
Ahmad, 2011, Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways, Toxicology, 290, 69, 10.1016/j.tox.2011.08.020
Vinothkumar, 2011, Chemopreventive efficacy of geraniol against 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis, Redox Rep, 16, 91, 10.1179/174329211X13020951739839
Khan, 2013, Geraniol attenuates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced oxidative stress and inflammation in mouse skin: Possible role of p38 MAP Kinase and NF-κB, Exp Mol Pathol, 94, 419, 10.1016/j.yexmp.2013.01.006
Madankumar, 2013, Geraniol modulates tongue and hepatic phase I and phase II conjugation activities and may contribute directly to the chemopreventive activity against experimental oral carcinogenesis, Eur J Pharmacol, 705, 148, 10.1016/j.ejphar.2013.02.048
Wittig, 2015, Geraniol suppresses angiogenesis by down-regulating vascular endothelial growth factor (VEGF)/VEGFR-2 signaling, PLoS One, 10, e0131946, 10.1371/journal.pone.0131946
Gysin, 2011, Therapeutic strategies for targeting ras proteins, Genes Cancer, 2, 359, 10.1177/1947601911412376
Wallace, 2007, Targeting polyamine metabolism: A viable therapeutic/preventative solution for cancer?, Expert Opin Pharmacother, 8, 2109, 10.1517/14656566.8.13.2109
Peters, 2002, Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism, Biochim Biophys Acta, 1587, 194, 10.1016/S0925-4439(02)00082-0
Popat, 2004, Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis, J Clin Oncol, 22, 529, 10.1200/JCO.2004.05.064
Topolcan, 2008, The role of thymidine kinase in cancer diseases, Expert Opin Med Diagn, 2, 129, 10.1517/17530059.2.2.129
Jin, 2013, Inhibitory effect of geraniol in combination with gemcitabine on proliferation of BXPC-3 human pancreatic cancer cells, J Int Med Res, 41, 993, 10.1177/0300060513480919
Polo, 2011, Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line, Cell Biochem Funct, 29, 452, 10.1002/cbf.1772
Yu, 1995, Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice, J Nutr, 125, 2763
Shoff, 1991, Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol, Cancer Res, 51, 37
He, 1997, Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo, J Nutr, 127, 668, 10.1093/jn/127.5.668
Mo, 2000, Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas, Cancer Lett, 157, 145, 10.1016/S0304-3835(00)00490-0
McAnally, 2003, Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells, Cancer Lett, 202, 181, 10.1016/j.canlet.2003.08.008
Aqil, 2013, Bioavailability of phytochemicals and its enhancement by drug delivery systems, Cancer Lett, 334, 133, 10.1016/j.canlet.2013.02.032
Chung, 2011, Developmental and pathological angiogenesis, Annu Rev Cell Dev Biol, 27, 563, 10.1146/annurev-cellbio-092910-154002
DeBose-Boyd, 2008, Feedback regulation of cholesterol synthesis: Sterol-accelerated ubiquitination and degradation of HMG CoA reductase, Cell Res, 18, 609, 10.1038/cr.2008.61
Chun, 2014, A network perspective on unraveling the role of TRP channels in biology and disease, Pflugers Arch, 466, 173, 10.1007/s00424-013-1292-2
Barabási, 2011, Network medicine: A network-based approach to human disease, Nat Rev Genet, 12, 56, 10.1038/nrg2918
Furlong, 2013, Human diseases through the lens of network biology, Trends Genet, 29, 150, 10.1016/j.tig.2012.11.004
Grossglauser, 2014, Data-driven healthcare: From patterns to actions, Eur J Prev Cardiol, 21, 14, 10.1177/2047487314552755
Lusher, 2014, Data-driven medicinal chemistry in the era of big data, Drug Discov Today, 19, 859, 10.1016/j.drudis.2013.12.004
Quan, 2014, Dissecting traditional Chinese medicines by omics and bioinformatics, Nat Prod Commun, 9, 1391
Quinn, 2013, Repositioning metformin for cancer prevention and treatment, Trends Endocrinol Metab, 24, 469, 10.1016/j.tem.2013.05.004
Anisimov, 2014, Do metformin a real anticarcinogen? A critical reappraisal of experimental data, Ann Transl Med, 2, 60